The only issue with ILA is when is the Phase 2 trial going to start.
It was originally this quarter. Then next quarter.
From the quarterly : "Island is collaborating with the State University of New York (SUNY) Upstate in Syracuse for
the ISLA-101 Phase II Clinical Trial. The Company has maintained frequent communication
with collaborators at SUNY Upstate to continue planning for the dengue human infection
model (DHIM) Phase 2 clinical trial and is currently working towards completion of a Clinical
Trial agreement. An update on this agreement is expected shortly."
- Forums
- ASX - By Stock
- ISLAND PHARMACEUTICALS LIMITED ILA IPO Analysis
The only issue with ILA is when is the Phase 2 trial going to...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ILA (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.620M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 74360 | 6.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.3¢ | 31460 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 74360 | 0.063 |
2 | 4444 | 0.062 |
2 | 22000 | 0.060 |
1 | 17100 | 0.058 |
1 | 15000 | 0.057 |
Price($) | Vol. | No. |
---|---|---|
0.073 | 31460 | 2 |
0.076 | 620 | 1 |
0.080 | 100000 | 1 |
0.090 | 24805 | 1 |
0.000 | 0 | 0 |
Last trade - 10.04am 16/07/2024 (20 minute delay) ? |
Featured News
ILA (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online